arrow
N

Nicolas Fischer

novimmune sa
H指数:22
被引数:2,297

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies

使用配对双特异性抗体在肿瘤微环境中选择性激活白细胞介素-2/白细胞介素-15受体信号通路

2025-03-250
OA
NI-2901, an affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade
2023-04-040
PRE
Combination of.. bispecific antibodies targeting innate (CEAxCD47, NILK-2401) and adaptive immunity (CEAxCD3, NILK-2301 and CEAxCD28, NILK-3301) for next generation immunotherapy of CEA-expressing cancers
2023-04-040
PRE
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia

安全有效靶向CD19和CD47的双特异性抗体的临床前开发,用于治疗b细胞淋巴瘤和白血病

2018-07-31100
OAAI
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes
2016-01-2550
OAAI